Table 5.
Drugs with significant anticholinergic effect; all treatment and subgroups. Treatment prevalence in nursing home residents.
| N = 574 | Number of drugs with significant anticholinergic effect |
|||||
|---|---|---|---|---|---|---|
| 0 | ≥1 | 1 | 2 | 3 | ||
| Kind of anticholinergic treatment | All treatment, regularly and as needed, n (%) | 499 (86.9) | 75 (13.1) | 65 (11.3) | 9 (1.6) | 1 (0.2) |
| All treatment, regularly, n (%) | 536 (93.4) | 38 (7.6) | 35 (6.1) | 3 (0.5) | 0 (0.0) | |
| Yes | No | |||||
| Drugs for urinary frequency and incontinence1, n (%) | 4 (0.7) | 570 (99.3) | ||||
| Hydroxyzine/Promethazine/Alimemazine2, n (%) | 44 (7.7) | 530 (92.3) | ||||
1
ATC-code G04BD excl. G04BD12 (mirabegron).
2
Treatment with one of these drugs.